High Tide Inc. (HITI) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $221.43M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Pharmaceuticals |
| Country | CA | CEO | Harkirat Grover |
| IPO Date | 2021-01-08 | CAGR | 60.63% |
| Employees | 1,832 | Website | www.hightideinc.com |
| Div. Yield | — | Payout Ratio | -3% |
| Buy Back Yield | — | Total Yield | — |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $272.80M | P/E | -7.39 | Forward P/E | 15.59 | PEG | — |
| P/S | 0.02 | P/B | 0.05 | P/CF | 0.11 | P/FCF | 0.18 |
| Sales | $479.70M | Sales 1Y | 22.05% | Sales 3Y | 52.69% | Sales 5Y | 416.11% |
| EPS | $-0.34 | EPS 1Y | 607.48% | EPS 3Y | -41.51% | EPS 5Y | -36.51% |
| Sales QoQ | 0.35% | EPS QoQ | -115.94% | Sales QoQ Avg | 6.86% | EPS QoQ Avg | -2020.66% |
| Gross Margin | 17.52% | Operating Margin | 3.29% | Profit Margin | -6.56% | ROCE | 8.57% |
| ROA | -13% | ROE | -43% | Altman Z Score | 1.54 | Piotroski Score | 3 |
| Current Ratio | 1.46 | Quick Ratio | 0.66 | Cash Ratio | 0.41 | Op. CF Ratio | 0.05 |
| Debt/Equity | 0.21 | Debt/Assets | 0.05 | Lt Debt/Equity | — | Lt Debt/Cap. | — |
| Intrst Cov. | 1.35 | Inventory Turnover | 7.72 | Asset Turnover | 1.93 | Receivables Turnover | 86.95 |
| Enterprise Value | $272.80M | P/E Ratio | -7.39 |
| Forward P/E | 15.59 | PEG Ratio | — |
| P/S Ratio | 0.02 | P/B Ratio | 0.05 |
| P/CF Ratio | 0.11 | P/FCF Ratio | 0.18 |
| EPS | $-0.34 | EPS Growth 1Y | 607.48% |
| EPS Growth 3Y | -41.51% | EPS Growth 5Y | -36.51% |
| Revenue Growth 1Y | 22.05% | Gross Margin | 0.18% |
| Operating Margin | 0.03% | Profit Margin | -0.07% |
| ROE | -0.43% | ROA | -0.13% |
| ROCE | 0.09% | Current Ratio | 1.46 |
| Quick Ratio | 0.66 | Cash Ratio | 0.41 |
| Debt/Equity | 0.21 | Interest Coverage | 1.35 |
| Altman Z Score | 1.54 | Piotroski Score | 3 |
High Tide Inc. (HITI) valuation & financials
High Tide Inc. (HITI) has a market capitalization of $221.43M and trades at a price-to-earnings ratio of -7.4. It operates in the Healthcare sector (Medical - Pharmaceuticals).
High Tide Inc.'s revenue grew +22.0% over the last year.
High Tide Inc.'s next earnings report is scheduled for September 14, 2026 after market close; analysts estimate EPS of $0.01. Check the earnings calendar to see all companies reporting this week.
High Tide Inc. (HITI) — frequently asked questions
When does High Tide Inc. (HITI) report earnings next?
High Tide Inc. is expected to report earnings on September 14, 2026 after market close. Analysts estimate EPS of $0.01.
What is High Tide Inc.'s market cap?
High Tide Inc. (HITI) has a market capitalization of $221.43M.
What is HITI's P/E ratio?
High Tide Inc. trades at a price-to-earnings ratio of -7.4, with trailing twelve-month EPS of $-0.34.
How fast is High Tide Inc. growing?
High Tide Inc.'s revenue grew +22.0% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)